PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 164 filers reported holding PRECIGEN INC in Q3 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -90.5% | 4,255 | -92.2% | 0.00% | – |
| Q2 2023 | $63 | -28.4% | 54,898 | -34.3% | 0.00% | – |
| Q1 2023 | $88 | -14.6% | 83,520 | +22.4% | 0.00% | – |
| Q4 2022 | $103 | -100.0% | 68,231 | -30.6% | 0.00% | – |
| Q3 2022 | $208,000 | +173.7% | 98,262 | +73.1% | 0.00% | – |
| Q2 2022 | $76,000 | -64.0% | 56,778 | -43.2% | 0.00% | – |
| Q1 2022 | $211,000 | -27.7% | 100,045 | +26.7% | 0.00% | – |
| Q4 2021 | $292,000 | +648.7% | 78,944 | +1219.3% | 0.00% | – |
| Q3 2021 | $39,000 | +225.0% | 5,984 | +209.9% | 0.00% | – |
| Q2 2021 | $12,000 | – | 1,931 | -83.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 11,381 | -36.6% | 0.00% | – |
| Q4 2020 | $182,000 | -35.2% | 17,938 | -77.7% | 0.00% | – |
| Q3 2020 | $281,000 | – | 80,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |